What is the treatment for a patient with Catheter-Related Bloodstream Infection (CRBSI) and different cultures on 2 sites?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for CRBSI with Different Cultures from Two Sites

When you have different organisms growing from two different blood culture sites in a patient with suspected CRBSI, you must first confirm whether this represents true CRBSI versus contamination or polymicrobial bacteremia from another source—obtain additional paired blood cultures (catheter hub and peripheral vein) before making treatment decisions. 1

Diagnostic Clarification Required

The presence of different organisms from two culture sites creates diagnostic uncertainty that must be resolved before proceeding with definitive treatment:

  • If one site shows coagulase-negative staphylococci and the other shows a different organism, obtain additional blood cultures from both the catheter hub and a peripheral vein to rule out contamination, as a single positive culture growing coagulase-negative staphylococci may represent contamination rather than true infection. 1

  • For definitive CRBSI diagnosis, you need the same organism growing from both a peripheral blood culture and either the catheter tip culture OR paired blood cultures meeting quantitative criteria (≥3-fold higher colony count from catheter) or differential time to positivity (≥2 hours earlier growth from catheter). 1, 2

Treatment Algorithm When Different Organisms Are Confirmed

Step 1: Initiate Empiric Broad-Spectrum Therapy Immediately

While awaiting clarification of the microbiology:

  • Start vancomycin for gram-positive coverage (including MRSA) in healthcare settings with elevated MRSA prevalence. 1, 2
  • Add gram-negative coverage with a fourth-generation cephalosporin, carbapenem, or β-lactam/β-lactamase inhibitor combination based on your local antibiogram. 2, 3
  • Consider adding antifungal coverage (echinocandin or fluconazole) if the patient has risk factors: total parenteral nutrition, prolonged broad-spectrum antibiotics, hematologic malignancy, transplant recipient, femoral catheterization, or Candida colonization at multiple sites. 1

Step 2: Catheter Management Decision

Remove the catheter immediately if any of the following apply:

  • Short-term catheters: Remove for CRBSI due to gram-negative bacilli, S. aureus, enterococci, fungi, or mycobacteria. 1, 3
  • Long-term catheters: Remove for severe sepsis, suppurative thrombophlebitis, endocarditis, persistent bloodstream infection >72 hours despite appropriate therapy, or infections due to S. aureus, P. aeruginosa, fungi, or mycobacteria. 1, 2
  • Any catheter type: Remove if there is purulence at the exit site, tunnel infection, or hemodynamic instability. 2, 3

Step 3: Obtain Follow-Up Cultures at 72 Hours

  • Draw repeat blood cultures 72 hours after initiating appropriate antimicrobial therapy to document clearance of bacteremia. 1, 2, 3
  • If cultures remain positive at 72 hours, remove the catheter (if not already removed) and extend therapy to 4-6 weeks, as this indicates complicated infection. 1, 2, 3

Pathogen-Specific Treatment Duration

Once you have clarified which organism(s) represent true CRBSI:

For Uncomplicated CRBSI (after catheter removal):

  • Coagulase-negative staphylococci: 5-7 days (or 10-14 days per standard recommendation). 2
  • S. aureus: Minimum 14 days. 2
  • Enterococcus: 7-14 days. 2
  • Gram-negative bacilli: 7-14 days (10-14 days for Klebsiella and similar organisms). 2, 3
  • Candida species: 14 days after first negative blood culture. 2

For Complicated CRBSI:

  • Persistent bacteremia/fungemia >72 hours after catheter removal: 4-6 weeks. 1, 2, 3
  • Endocarditis or suppurative thrombophlebitis: 4-6 weeks. 1, 2
  • Osteomyelitis: 4-6 weeks (pediatric) or 6-8 weeks (adults). 1

Critical Pitfalls to Avoid

  • Do not assume polymicrobial CRBSI without confirming both organisms meet diagnostic criteria—one may represent contamination, especially if coagulase-negative staphylococci are involved. 1
  • Do not delay catheter removal in short-term catheters with gram-negative bacilli or S. aureus, as mortality increases 5-fold when treated with antibiotics alone without removal. 1, 4
  • Do not attempt catheter salvage for S. aureus, P. aeruginosa, or Candida species in any catheter type unless there are absolutely no alternative access sites. 1
  • Always clean catheter hubs meticulously with alcohol, alcoholic chlorhexidine (>0.5%), or tincture of iodine before drawing blood cultures to minimize contamination. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

CRBSI Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Klebsiella-Related CRBSI in Temporary Catheters

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What antibiotic is suggested for a 56-year-old female patient with Chronic Kidney Disease (CKD) stage 5, presenting with pus at the Central Venous Catheter (CVC) femoral insertion site?
What is the recommended treatment for a patient with a catheter-related bloodstream infection (CRBSI) due to Enterococcus faecalis and Enterobacter cloacae?
What is the best treatment approach for an adult patient with chronic kidney disease (CKD) on dialysis, presenting with a catheter-related bloodstream infection (CRBSI) due to Staphylococcus hominis and Salmonella, and a respiratory infection with ESBL (Extended-Spectrum Beta-Lactamase) Klebsiella pneumoniae and Pseudomonas aeruginosa?
What are the management guidelines for a patient suspected of having a Catheter Related Blood Stream Infection (CRBSI)?
What is the recommended treatment for bacteremia following hemodialysis in a patient with impaired renal function?
What are the contraindications for intravenous (IV) thiamine administration in patients with suspected thiamine deficiency, particularly those with a history of alcohol use disorder (AUD) or at risk for Wernicke's encephalopathy?
What education should be provided to a patient with a hemoglobin A1c (HbA1c) level of 6.2%, indicating prediabetes or early diabetes?
What are the hemodynamic and inflammatory processes that lead to Chronic Kidney Disease (CKD) in patients with pre-existing conditions like diabetes or hypertension?
What is the best approach to manage a patient in their sixties with uncontrolled Type 2 Diabetes Mellitus (HbA1c of 8.4%) who is currently taking Farxiga (dapagliflozin) and Actos (pioglitazone) in addition to Lantus (insulin glargine) and glipizide, considering a switch to Synjardy (empagliflozin/metformin combination) for improved glycemic control and renal/cardiovascular benefits?
What is the role of the ROX (Rapid Oxygenation and Respiratory) index in predicting successful weaning from mechanical ventilation in critically ill patients?
What are the top daily medications for a patient with Short-Lasting Unilateral Neuralgiform Headache with Conjunctival Injection and Tearing (SUNCT) syndrome, starting from the best based on existing guidelines?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.